Sagient Research Products About Us Contact Us
Coverage Universe
  Drugs Covered: 3,034
  Drugs Evaluated: 308
  Revenue Models: 462
  Companies Covered: 781
  Companies Evaluated:  33

>> Advanced Catalyst Search <<

>> Advanced Drug Search <<

>> Advanced Event Search <<

Search
Catalysts Drug Profiles
Impact Events Company Profiles
Target    Indication   
Sample Reports
Special Reports
05/05/08 Bipolar Indication Report
02/01/08 2008 BioMedTracker Outlook
01/08/08 FDA Approval Study
12/18/07 2007 Post-ASH Report
12/12/07 Kuvan PDUFA Sensitivity Analysis
12/07/07 Multiple Sclerosis (MS) Indication Report
12/04/07 2007 Pre-ASH Report
11/09/07 BioMarin (BMRN) Valuation Update   More...
Evidenced-Based Investment Research
Event Alerts
Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
05/09/08 Novogen (NVGN) Phenoxodiol for Ovarian Cancer Subscribers Only Subscribers Only     Subscribers Only
05/09/08 Takeda (4502.T) Velcade for Multiple Myeloma (MM) Subscribers Only Subscribers Only     Subscribers Only
05/09/08 Adolor (ADLR) Entereg for Postoperative Ileus Subscribers Only Subscribers Only     Subscribers Only
05/09/08 Roche (RHHBY) Actemra for Rheumatoid Arthritis (RA) Subscribers Only Subscribers Only     Subscribers Only
05/09/08 Vanda (VNDA) Fanapta for Schizophrenia Subscribers Only Subscribers Only     Subscribers Only
More...

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
05/10/08        Subscribers Only      Subscribers Only       Trial Data - Updated Results      
05/12/08        Subscribers Only      Subscribers Only       Company - Earnings Announcement      
05/12/08        Subscribers Only      Subscribers Only       Company - Earnings Announcement      
05/12/08        Subscribers Only      Subscribers Only       Company - Earnings Announcement      
05/12/08        Subscribers Only      Subscribers Only       Company - Earnings Announcement      
More...

Online Demo   

 
 Questions? Email Customer Support Privacy Policy     Important Legal Disclosure 

Copyright © 2008 Sagient Research Systems, Inc.  All rights reserved.